First Drug To Prevent HIV Takes A Step Closer To Approval

May 9, 2012 | By
Bookmark and Share

The daily pill, that could soon be approved by the FDA for preventing HIV in high-risk patients.

Some argue the wide availability of such a drug would discourage safe sex and increase incidence of HIV.

A pill to prevent HIV could soon be available in what would be a major breakthrough in the 30-year campaign against the AIDS epidemic.

Truvada is currently used to treat the virus, but tests have shown it to be safe and effective in healthy people for preventing it.

The Food and Drug Administration concluded that taking the pill daily could spare patients ‘infection with a serious and life-threatening illness that requires lifelong treatment’.

Tomorrow a panel of FDA advisers will consider the review when it votes on whether Truvada, which was created by Gilead Sciences, should be approved as a preventative treatment for people who are at high risk of contracting HIV through sexual intercourse.

The FDA is not required to follow the advice of its panels, but it usually does.

An estimated 1.2 million Americans have HIV, which attacks the immune system and, unless treated with antiviral drugs, develops into AIDS, a fatal condition in which the body cannot fight off infections.

Read the whole story:  Mail Online

  • Facebook
  • Twitter
  • Google Plus
  • Pinterest
  • Email

Tags: , , , , ,


Comments are closed.

Welcome to Fumua


Lost your password?


Registration is closed

Sorry, you are not allowed to register by yourself on this site!

You must either be invited by one of our team member or request an invitation by emailing the site administrator at